Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease

Background/Aim: Pemetrexed plus platinum followed by pemetrexed maintenance has been one of the standard first-line treatments in advanced nonsquamous non-small cell lung cancer (NSCLC), but little is known regarding its safety and efficacy for patients with interstitial lung disease (ILD). Patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:In Vivo
Hlavní autoři: FUJITA, TETSUO, KUROKI, TSUGUKO, HAYAMA, NAMI, SHIRAISHI, YUKA, AMANO, HIROYUKI, NAKAMURA, MAKOTO, HIRANO, SATOSHI, TABETA, HIROSHI, NAKAMURA, SUKEYUKI
Médium: Artigo
Jazyk:Inglês
Vydáno: International Institute of Anticancer Research 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899148/
https://ncbi.nlm.nih.gov/pubmed/31662538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11704
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky